Showing 281-290 of 295 results for "".
- New Line of Laser Systems Now Available from Sensus Healthcarehttps://modernaesthetics.com/news/new-line-of-lasers-systems-now-available-from-sensus-healthcare/2472120/Sensus Healthcare, Inc. has launched Sensus Laser Systems, a unique multi-platform line of high-quality, cost-effective lasers for hair and tattoo removal, acne lesion correction, skin rejuvenation and pigmentation/large pore treatment. Prior to this launch, the medical device company specialized
- Art Lesson Teaches Plastic Surgeons Better Botox Injection Techniqueshttps://modernaesthetics.com/news/art-lesson-teaches-plastic-surgeons-better-botox-injection-techniques-facebookshare-to/2472207/A highly detailed body painting project helps plastic surgeons understand how underlying muscles contribute to facial lines and wrinkles as well as how to better treat them using botulinum toxin injections. The illustrated article, which appears in Plas
- Allergan CEO Calls for Consensus on Medical Aesthetic Treatment in Minorshttps://modernaesthetics.com/news/allergan-ceo-calls-for-consensus-on-medical-aesthetic-treatment-in-minors/2472213/Allergan Chairman & CEO Brent Saunders, the father of two high school-aged girls, is speaking up and out about the risks associated with offering medical aesthetic treatments to minors. In a new blog post, he writes “we must remember that anyone under the age of 18 is still matu
- Survey: Many Bothered By Double Chins, Take Steps To Cover Uphttps://modernaesthetics.com/news/survey-many-bothered-by-double-chins-take-steps-to-cover-up/2472259/Close to 50 percent of individuals are bothered by the appearance of the area under their chin, and many alter their behavior as a result, according to a new survey commissioned by Allergan plc.<
- Allergan Agrees to Acquire ZELTIQ for $2.47 Billionhttps://modernaesthetics.com/news/allergan-agrees-to-acquire-zeltiq-for-247-billion/2472280/Allergan plc and ZELTIQ® Aesthetics, Inc. have entered into a definitive agreement under which Allergan has agreed to acquire ZELTIQ for $56.50 per share, or $2.475 billion, subject to customary
- Allergan Launches Juvéderm Volitehttps://modernaesthetics.com/news/allergan-launches-juvderm-volite/2472287/Allergan plc launched Juvéderm Volite, an injectable product specifically designed to improve skin quality and last up to nine months with just one treatment session. This innovative new Allergan product uses the unique patented Vycross technology. The new HA injectable treatment d
- Robin Unger, MDhttps://modernaesthetics.com/profiles/robin-unger-md/Lze24l/
- Mitchel Goldman, MDhttps://modernaesthetics.com/profiles/mitchel-goldman-md/p7vzp7/Dr. Mitchel Goldman is an Associate Clinical Professor of Dermatology/Medicine, University of California, San Diego. Dr. Goldman is an expert in the areas of dermatology, phlebology, laser surgery, and liposuction. He is especially renowned for his pioneering research and development of multiple la…
- Jonathan Kaplanhttps://modernaesthetics.com/profiles/jonathan-kaplan/OwPl6L/Univ of Illinois COM @ Chicago
- Jeanette Blackhttps://modernaesthetics.com/profiles/jeanette-black/7vZak7/Tulane Univ SOM